Previous research indicated that NEURL1B was low expressed in colon cancer, and its low expression predicted a shorter survival time, suggesting that NEURL1B, as a tumor suppressor gene, participated in the pathological processes of colon cancer and may be served as potential biomarkers for early diagnosis and prognostic evaluation.25 Here, NEURL1B is linked to neoplasm.